Maman Biomedical

About us

Fertility treatment as it exists today is financially, physically, mentally, and emotionally taxing on individuals and couples seeking assisted pregnancies or social egg freezing. Despite the many advances in fertility treatment over the years, there exists no method that completely eliminates the burden of multiple daily injections over consecutive days for women undergoing fertility treatment.

This demonstrates a need for continued advancement and innovation in a field which will see some 7 million couples experiencing infertility by 2030.

Maman Biomedical is developing disruptive interventions to improve the fertility treatment experience by eliminating the pain, trauma, uncertainty and inconvenience of taking 2-5 injections per day, every day for up to 14 days during a typical treatment cycle.

Program engagement

Maman Biomedical

Leadership

Latchmi Raghunanan

Co-founder and CEO

Roopchand Raghunanan

Co-founder and COO

Status

Intellectual Property

Fundraising

Sector

Subsector

Synapse Life Science Pitch Competition applications open. Apply by November 10, 2024

Applications for the 2025 Synapse Competition are open!

The Synapse Life Science Competition combines the ideas and research of life science innovators with the intellect and strategy of students. Finalists receive training, mentorship, a $2,000 grant and a chance to pitch and compete for BIG cash prizes!

Applications close on November 10, 2024.